Find out how Sierra Oncology Inc. (SRRA) stock typically trades around earnings. Identify which days the stock was most volatile and its historical price reaction. SRRA Stock Predictions & Forecast - SRRA Buy or Sell? SRRA Stock Forecast. The SRRA Stock Prediction is based on short term trend analysis and is best used for short term swing traders or day traders rather than long term investors.. Get a FREE analysis on SRRA now. SRRA Stock Analysis. SRRA is down -3.02% on 03/30/20 and has lost a total of …

SRRA Price Target and Analyst Ratings (Sierra Oncology) Nov 06, 2019 · Their average twelve-month price target is $1.20, suggesting that the stock has a possible downside of 86.65%. The high price target for SRRA is $1.20 and the low price target for SRRA is $1.20. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy." MARA Marathon Patent Group, Inc. — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

$SRRA Stock Technical Analysis | Sierra Oncology ...

SRRA Stock Experts, Stock Prediction, Analysis - Trader ... A stock expert is a trading system that specializes in trading a single stock. In this case, the stock experts on this page only trade SRRA. Predictions for SRRA This table shows you the predictions on SRRA for a handful of our stock experts. SRRA: ProNAi Therapeutics, Inc. - Brokerage ... SRRA: ProNAi Therapeutics, Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research.

Sierra Oncology Inc Stock (SRRA): Technical & Fundamental ...

Sierra Oncology, Inc () Stock Market infoRecommendations: Buy or sell Sierra Oncology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Sierra Oncology share forecasts, stock quote and buy / sell signals below.According to present data Sierra Oncology's SRRA shares and potentially its market environment have been in a bullish cycle in the last 12 Pronai Therapeutics, Inc. - SRRA - Stock Price Today - Zacks View ProNAi Therapeutics, Inc. SRRA investment & stock information. Get the latest ProNAi Therapeutics, Inc. SRRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SRRA Sierra Oncology Inc — Stock Price and ... - StockTwits

Sierra Oncology (SRRA) stock price prediction is 7.725 USD. The Sierra Oncology stock forecast is 7.725 USD for 2021 February 09, Tuesday with technical analysis.

Sierra Oncology, Inc () Stock Market infoRecommendations: Buy or sell Sierra Oncology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Sierra Oncology share forecasts, stock quote and buy / sell signals below.According to present data Sierra Oncology's SRRA shares and potentially its market environment have been in a bullish cycle in the last 12 Pronai Therapeutics, Inc. - SRRA - Stock Price Today - Zacks View ProNAi Therapeutics, Inc. SRRA investment & stock information. Get the latest ProNAi Therapeutics, Inc. SRRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SRRA Sierra Oncology Inc — Stock Price and ... - StockTwits Apr 03, 2020 · Real-time trade and investing ideas on Sierra Oncology Inc SRRA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. SRRA Stock Prediction and Analysis - Trader Bots - Making ... The stock analysis for SRRA is based on the analysis and stock picks of our best trading systems. By aggregating the opinions and predictions of our best trading systems (trading bots), we come up with a general prediction.

SRRA Stock Price | Sierra Oncology Inc. Stock Quote (U.S ...

Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Apr 03, 2020 · VANCOUVER, Feb. 6, 2020 Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today announced that the Series A convertible voting preferred stock